ARQT position history
The shares of Arcutis Biotherapeutics (ARQT) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 504,700 shares, $15M, 0.04% of portfolio, New
- 2026 Q1: 1,072,189 shares, $25M, 0.08% of portfolio, Add +112.4%
- 2026 Q2: 1,253,120 shares, $33M, 0.05% of portfolio, Add +16.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|